LNA-anti-miR-150 alleviates renal interstitial fibrosis by reducing pro-inflammatory M1/M2 macrophage polarization

Xiangnan Hao1, Junjun Luan1, Congcong Jiao1

  • 1Department of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China.

Frontiers in Immunology
|August 22, 2022
PubMed

Insights

Locked nucleic acid-anti-miR-150 therapy reduces renal interstitial fibrosis in mice. This treatment targets the SOCS1/JAK/STAT pathway and decreases pro-inflammatory macrophage polarization, offering a potential therapeutic strategy for kidney fibrosis.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Immunology

Background:

  • Renal interstitial fibrosis (RIF) is a common outcome of acute kidney injury with no effective treatments.
  • Locked nucleic acid-anti-miR-150 (LNA-anti-miR-150) has shown potential in antagonizing pro-fibrotic pathways in renal cells.
  • The SOCS1/JAK/STAT pathway and macrophage polarization are implicated in kidney fibrosis progression.

Purpose of the Study:

  • To investigate if LNA-anti-miR-150 can attenuate folic acid-induced RIF in mice.
  • To determine if LNA-anti-miR-150 regulates the SOCS1/JAK/STAT pathway in RIF.
  • To assess the effect of LNA-anti-miR-150 on M1/M2 macrophage polarization in RIF.

Main Methods:

  • Induction of RIF in mice using folic acid.
  • Administration of LNA-anti-miR-150 to RIF mice.
  • Histopathological analysis (PAS and Masson staining) for fibrosis.
  • Assessment of pro-fibrotic protein expression (alpha-smooth muscle actin, fibronectin).
  • Evaluation of SOCS1, p-JAK1, and p-STAT1 expression.
  • Analysis of macrophage infiltration (CD11c, CD206) and cytokine levels.

Main Results:

  • Folic acid-induced RIF mice showed increased miR-150, fibrosis, SOCS1 downregulation, and p-JAK1/p-STAT1 upregulation.
  • LNA-anti-miR-150 treatment alleviated RIF and reversed the molecular changes in the SOCS1/JAK/STAT pathway.
  • RIF mice exhibited increased macrophage infiltration (M1 and M2) and cytokine levels, which were attenuated by LNA-anti-miR-150.

Conclusions:

  • LNA-anti-miR-150 effectively alleviates renal interstitial fibrosis in a mouse model.
  • The therapeutic effect is associated with the regulation of the SOCS1/JAK/STAT pathway.
  • LNA-anti-miR-150 reduces pro-inflammatory M1 and M2 macrophage polarization, suggesting a novel therapeutic mechanism for RIF.

Related Concept Videos